Emma Morris and Iain McGill uncover the fascinating story behind Quell Therapeutics, revealing how a team of 6 top scientists came together to develop a pioneering cell and gene therapy that harnesses the body's immune response to prevent life-threatening organ transplant rejection. In this episode, we cover the cutting-edge science, top trends in precision medicine, and what it takes to build a successful biotech in just 2 years.

Karen Petersen shares her inspiring story, mapping her journey from cancer survivor to founder of Karen's Club – a not-for-profit designed to support patients of color considering taking part in oncology clinical trials. She explores challenging topics, including building trust in marginalized communities, to reveal how life science companies can break down barriers to help patients participate in life-saving research.

Building a successful healthcare start-up takes tremendous amounts of time, knowledge, and funding – and new ventures face roadblocks at every turn. So, how do entrepreneurs navigate this incredibly complex market? Frank Jaskulke, Vice President of Intelligence at The Medical Alley Association, shares the lessons he’s learned and reveals how he is helping start-ups to scale, pivot, and build the social capital essential for winning in business and staying at the forefront of innovation.